Take a virtual tour of all things POTELIGEO with these short, information-packed vignettes.
Explore the diverse patient population and key efficacy results of POTELIGEO vs vorinostat.1
Learn about the response of POTELIGEO in skin, based on a post-hoc analysis of data in the MAVORIC clinical trial.1
Look at the response of POTELIGEO in the blood, based on a post-hoc analysis of data in the MAVORIC clinical trial.1
Learn about the role of C-C chemokine receptor type 4 (CCR4) in mycosis fungoides (MF) and Sézary syndrome (SS), and how POTELIGEO kills CCR4+ malignant T-cells.1
See the results of post-MAVORIC trial analysis of safety in patients with POTELIGEO treatment exposure up to 5 years.
Easily access a wide array of downloadable brochures, forms, and fact sheets covering prescribing, reimbursement, and patient support.
Be sure to sign up so we can keep you informed of updates
and new materials in the POTELIGEO Digital Library.
Important Safety Information